Do I need to retest for HIV after receiving non-reactive results from the HIV Antigen/Antibody (Ag/Ab) Combo Electrochemiluminescence Immunoassay (ECLIA) method at 63 and 91 days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No Further Testing Required After 91 Days

You do not need to retest for HIV after receiving non-reactive results from the HIV Ag/Ab Combo ECLIA at both 63 and 91 days post-exposure, as this definitively rules out HIV infection. 1

Why 91 Days Is Conclusive

The CDC explicitly states that fourth-generation HIV Ag/Ab tests are considered conclusive after 12 weeks (84 days) of potential exposure. 1 Your testing at 91 days exceeds this threshold and provides definitive results.

Key timing considerations:

  • Fourth-generation Ag/Ab combination tests detect HIV approximately 18-45 days post-infection 1
  • The 12-week (84-day) window accounts for antiretroviral medication washout periods and the maximum window period of these tests 2
  • Your 91-day test result is 7 days beyond the recommended definitive testing timepoint 1

Understanding Your Test Results

The ECLIA method you received is a fourth-generation laboratory-based Ag/Ab test, which is the recommended standard for HIV screening. 2 These tests detect both:

  • HIV p24 antigen (appears earlier in infection)
  • HIV antibodies (IgM and IgG) 2

Performance characteristics:

  • Fourth-generation tests detect approximately 82% of acute infections that RNA testing would identify 3
  • In high-prevalence populations, these tests have 99.9% specificity 3
  • Two negative tests at 63 and 91 days provide extremely high confidence in excluding HIV infection 1

Important Caveats

The only scenario requiring additional testing would be if you:

  • Took post-exposure prophylaxis (PEP) or pre-exposure prophylaxis (PrEP) medications, as antiretrovirals can suppress viral load and delay seroconversion 2, 4
  • Had a new HIV exposure after your 91-day test
  • Received a cabotegravir injection within the past year 2

If you took PEP, the CDC recommends both laboratory Ag/Ab testing AND nucleic acid testing (NAT) at 12 weeks post-PEP initiation (not post-exposure) because antiretrovirals can mask infection. 2 However, if you had no PEP and no new exposures, your 91-day result is definitive.

Clinical Bottom Line

Your two non-reactive fourth-generation Ag/Ab tests at 63 and 91 days conclusively exclude HIV infection from any exposure that occurred more than 91 days ago. 1 No further testing is medically indicated unless you have ongoing risk behaviors or new exposures. 2

References

Guideline

HIV Diagnosis Using Fourth-Generation Tests

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Do I still need to test for HIV again after receiving negative results from the HIV Antigen/Antibody (Ag/Ab) Combo Electrochemiluminescence Immunoassay (ECLIA) method at 63 and 91 days post-exposure?
What is the next step in management for a patient with a negative Human Immunodeficiency Virus (HIV) 1/2 screen and repeatedly reactive HIV combination antibody/antigen (ab/ag) test?
What is the recommended initial screening test and treatment regimen for individuals suspected of having Human Immunodeficiency Virus (HIV) using the HIV Antigen/Antibody (Ag/Ab) Combo Electrochemiluminescence Immunoassay (ECLIA)?
Is a 4-month follow-up test necessary after negative HIV Antigen/Antibody (Ag/Ab) combo test results at 63 and 91 days post-exposure?
If an individual has a positive Human Immunodeficiency Virus (HIV) 1 and 2 antibody test but is HIV negative, will they always be positive for HIV 1 and 2 antibody?
What is the next step in managing a septated 2.9 cm cyst in the right hepatic lobe?
What NOAC regimen is recommended for a 30-year-old patient with cerebral venous sinus thrombosis, normal renal function, and no significant contraindications to anticoagulation?
What is the timeframe for developing end-stage renal disease (ESRD) in a patient with uncontrolled diabetes mellitus (DM)?
What are the management strategies for uncontrolled type 2 diabetes with impaired renal function?
When should Hepatitis B Immunoglobulin (HBIG) be administered after exposure to the Hepatitis B virus?
What are the treatment options for atrial fibrillation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.